کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3253638 | 1207139 | 2013 | 13 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las GuÃas Europeas de Prevención Cardiovascular 2012
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
Cardiovascular diseases - بیماری قلبی-عروقی Enfermedades cardiovasculares - بیماری های قلبی عروقیCardiovascular prevention - جلوگیری از قلب و عروقprevención cardiovascular - جلوگیری از قلب و عروقRiesgo cardiovascular - خطر قلبی عروقیCardiovascular risk - خطر قلبی و عروقیClinical practice guidelines - دستورالعمل های عمل بالینیGuías de práctica clínica - دستورالعمل های عمل بالینی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
غدد درون ریز، دیابت و متابولیسم
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las GuÃas Europeas de Prevención Cardiovascular 2012 Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las GuÃas Europeas de Prevención Cardiovascular 2012](/preview/png/3253638.png)
چکیده انگلیسی
Based on the two main frameworks for evaluating scientific evidence (SEC and GRADE) European cardiovascular prevention guidelines recommend interventions across all life stages using a combination of population-based and high-risk strategies with diet as the cornerstone of prevention. The evaluation of cardiovascular risk (CVR) incorporates HDL levels and psychosocial factors, a very high risk category, and the concept of age-risk. They also recommend cognitive-behavioural methods (e.g., motivational interviewing, psychological interventions) led by health professionals and with the participation of the patient's family, to counterbalance psychosocial stress and reduce CVR through the institution of positive habits such as a healthy diet, physical activity, smoking cessation, and adherence to treatment. Additionally, public health interventions - such as smoking ban in public areas or the elimination of trans fatty acids from the food chain - are also essential. Other innovations include abandoning antiplatelet therapy in primary prevention and the recommendation of maintaining blood pressure within the 130-139/80-85Â mmHg range in diabetic patients and individuals with high CVR. Finally, due to the significant impact on patient progress and medical costs, special emphasis is given to the low therapeutic adherence levels observed. In sum, improving cardiovascular prevention requires a true partnership among the political class, public administrations, scientific and professional associations, health foundations, consumer associations, patients and their families. Such partnership would promote population-based and individual strategies by taking advantage of the broad spectrum of scientific evidence available, from clinical trials to observational studies and mathematical models to evaluate population-based interventions, including cost-effectiveness analyses.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Avances en DiabetologÃa - Volume 29, Issue 4, JulyâAugust 2013, Pages 95-107
Journal: Avances en DiabetologÃa - Volume 29, Issue 4, JulyâAugust 2013, Pages 95-107
نویسندگان
Miguel Angel Royo-Bordonada, José MarÃa Lobos Bejarano, Fernando Villar Alvarez, Susana Sans, Antonio Pérez, Juan Pedro-Botet, Rosa MarÃa Moreno Carriles, Antonio Maiques, Ángel Lizcano, Vicenta Lizarbe, Antonio Gil Núñez, Francisco Fornés Ubeda,